For help on how to get the results you want, see our search tips.
11 results
Keyword Remove keyword
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
-
List item
Referral: Oxynal Targin and associated names
oxycodone hydrochloride, naloxone hydrochloride, Article 13 referrals
Status: European Commission final decision, opinion/position date: 23/10/2014, EC decision date: 22/12/2014, Last updated: 27/01/2015 -
List item
Referral: Kantos Master
beclometasone dipropionate, formoterol fumarate, associated names: Kantos, Formodual, Foster, Inuxair, Innovair and associated names, Article 13 referrals
Status: European Commission final decision, opinion/position date: 17/01/2013, EC decision date: 10/04/2013, Last updated: 02/05/2013 -
List item
Referral: Hiprabovis Pneumos
Mannheimia haemolytica biotype A serotype A1, inactivated cell free suspension containing leukotoxoid Ph. Eur., inactivated Histophilus somni Bailie strain, Article 78
Status: European Commission final decision, opinion/position date: 14/07/2011, EC decision date: 03/11/2011, Last updated: 12/12/2011 -
List item
Referral: Alpha2-adrenoreceptor agonists
Xylazine, medetomidine, detomidine, romifidine, Article 78
Status: European Commission final decision, opinion/position date: 12/11/2008, EC decision date: 30/04/2009, Last updated: 22/06/2009 -
List item
Referral: Pregsure BVD
inactivated Bovine Viral Diarrhoea (BVD) type 1 virus, cytopathogenic strain 5960, Article 78
Status: European Commission final decision, opinion/position date: 15/07/2010, EC decision date: 07/10/2010, Last updated: 22/10/2010 -
List item
Referral: Bayovac IBR Marker Vivum
bovine Herpes Virus type 1 (BHV-1), strain Difivac (IBR-Marker Virus, gE-negative), modified live (attenuated) virus, associated names: Rhinobovin, Marker lebend, Rhinobovin Marker live, RhinobovinMarker Viva, Rhinobovin Marker Attenuato, Rhinobovin Marker Viva Marcada, Article 78
Status: European Commission final decision, opinion/position date: 21/01/2000, EC decision date: 10/07/2000, Last updated: 05/08/2014 -
List item
Referral: Levonelle 1500 microgram tablets and associated names
levonorgestrel, Article 13 referrals
Status: European Commission final decision, opinion/position date: 26/05/2016, EC decision date: 01/08/2016, Last updated: 09/08/2016 -
List item
Referral: Norditropin
somatropin, associated names: Norditropin FlexPro, Norditropin NordiFlex, Norditropin SimpleXx, Article 13 referrals
Status: European Commission final decision, opinion/position date: 15/12/2011, EC decision date: 06/03/2012, Last updated: 19/04/2012 -
List item
Referral: Closamectin Pour-on Solution and associated names
ivermectin, closantel, Article 78
Status: European Commission final decision, opinion/position date: 08/10/2015, EC decision date: 22/03/2016, Last updated: 31/05/2016 -
List item
Referral: Cardioxane
dexrazoxane, Article 13 referrals
Status: European Commission final decision, opinion/position date: 19/07/2017, EC decision date: 19/07/2017, Last updated: 26/07/2017 -
List item
Referral: Basiron AC and associated names
benzoyl peroxide, Article 13 referrals
Status: European Commission final decision, opinion/position date: 28/03/2019, EC decision date: 04/07/2019, Last updated: 19/07/2019